TABLE OF CONTENTS
| | | | Volume 13, Issue 6 (December 2013) | | In this issue EELS Paper Consensus Articles Original Articles
Also new AOP | | | | Nature Collections TCGA pan-cancer analysis
The Cancer Genome Atlas Pan-cancer initiative examines the similarities and differences among the genomic and cellular alterations found in the first dozen tumor types to be profiled by TCGA. This first look across cancer offers new tools in genomics and bioinformatics and the prospect of repurposing targeted therapies directed by the molecular pathology of the tumors in addition to their clinical classification.
Access the Collection and accompanying Podcast, FREE at: www.nature.com/tcga
Produced with support from Illumina | | | | | EELS Paper | Top | | The potential impact of pharmacogenetic testing on medication adherenceS B Haga and N M A LaPointe Pharmacogenomics J 2013 13: 481-483; advance online publication, September 3, 2013; 10.1038/tpj.2013.33 Abstract | Full Text | | Consensus Articles | Top | | Pharmacogenetic and pharmacokinetic aspects of CYP3A induction by efavirenz in HIV patientsA Habtewold, W Amogne, E Makonnen, G Yimer, H Nylén, K-D Riedel, G Aderaye, L Bertilsson, J Burhenne, U Diczfalusy and E Aklillu Pharmacogenomics J 2013 13: 484-489; advance online publication, October 23, 2012; 10.1038/tpj.2012.46 Abstract | Full Text | | | | COMT Val158Met modulates subjective responses to intravenous nicotine and cognitive performance in abstinent smokersA I Herman, P I Jatlow, J Gelernter, J B Listman and M Sofuoglu Pharmacogenomics J 2013 13: 490-497; advance online publication, March 5, 2013; 10.1038/tpj.2013.1 Abstract | Full Text | | Original Articles | Top | | A systematic review and meta-analysis of MTHFR polymorphisms in methotrexate toxicity prediction in pediatric acute lymphoblastic leukemiaE Lopez-Lopez, I Martin-Guerrero, J Ballesteros and A Garcia-Orad Pharmacogenomics J 2013 13: 498-506; advance online publication, October 23, 2012; 10.1038/tpj.2012.44 Abstract | Full Text | | | | Impact of ABCC2 polymorphisms on high-dose methotrexate pharmacokinetics in patients with lymphoid malignancyN Simon, A Marsot, E Villard, S Choquet, H-X Khe, N Zahr, P Lechat, V Leblond and J-S Hulot Pharmacogenomics J 2013 13: 507-513; advance online publication, October 16, 2012; 10.1038/tpj.2012.37 Abstract | Full Text | | | | Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parametersJ Graessler, Y Qin, H Zhong, J Zhang, J Licinio, M-L Wong, A Xu, T Chavakis, A B Bornstein, M Ehrhart-Bornstein, V Lamounier-Zepter, T Lohmann, T Wolf and S R Bornstein Pharmacogenomics J 2013 13: 514-522; advance online publication, October 2, 2012; 10.1038/tpj.2012.43 Abstract | Full Text | | | | Association among ORMDL3 gene expression, 17q21 polymorphism and response to treatment with inhaled corticosteroids in children with asthmaV Berce, C E P Kozmus and U Potočnik Pharmacogenomics J 2013 13: 523-529; advance online publication, September 18, 2012; 10.1038/tpj.2012.36 Abstract | Full Text | | | | A genetic basis for the variable effect of smoking/nicotine on Parkinson’s diseaseE M Hill-Burns, N Singh, P Ganguly, T H Hamza, J Montimurro, D M Kay, D Yearout, P Sheehan, K Frodey, J A Mclear, M B Feany, S D Hanes, W J Wolfgang, C P Zabetian, S A Factor and H Payami Pharmacogenomics J 2013 13: 530-537; advance online publication, October 2, 2012; 10.1038/tpj.2012.38 Abstract | Full Text | | | | APOE ε4, an Alzheimer’s disease susceptibility allele, and smoking cessationR L Ashare, J H Karlawish, E P Wileyto, A Pinto and C Lerman Pharmacogenomics J 2013 13: 538-543; advance online publication, December 18, 2012; 10.1038/tpj.2012.49 Abstract | Full Text | | | | Influence of FMO1 and 3 polymorphisms on serum olanzapine and its N-oxide metabolite in psychiatric patientsM M Söderberg, T Haslemo, E Molden and M-L Dahl Pharmacogenomics J 2013 13: 544-550; advance online publication, November 13, 2012; 10.1038/tpj.2012.47 Abstract | Full Text | | | | Mutations in monoamine oxidase (MAO) genes in mice lead to hypersensitivity to serotonin-enhancing drugs: implications for drug side effects in humansM A Fox, M G Panessiti, P R Moya, T J Tolliver, K Chen, J C Shih and D L Murphy Pharmacogenomics J 2013 13: 551-557; advance online publication, September 11, 2012; 10.1038/tpj.2012.35 Abstract | Full Text | | | | Multi-ethnic cytochrome-P450 copy number profiling: novel pharmacogenetic alleles and mechanism of copy number variation formationS Martis, H Mei, R Vijzelaar, L Edelmann, R J Desnick and S A Scott Pharmacogenomics J 2013 13: 558-566; advance online publication, November 20, 2012; 10.1038/tpj.2012.48 Abstract | Full Text | | | | Influence of admixture components on CYP2C9*2 allele frequency in eight indigenous populations from Northwest MexicoM Sosa-Macías, B P Lazalde-Ramos, C Galaviz-Hernández, H Rangel-Villalobos, J Salazar-Flores, V M Martínez-Sevilla, M L Martínez-Fierro, P Dorado, M L Wong, J Licinio and A LLerena Pharmacogenomics J 2013 13: 567-572; advance online publication, January 29, 2013; 10.1038/tpj.2012.52 Abstract | Full Text | | | | Advertisement | |
Discover the benefits of publishing with Molecular Psychiatry: the Open Access option
Molecular Psychiatry, the #1 journal in psychiatry, offers authors the option to publish their articles with immediate open access and exposure upon publication.
Visit the Author Page for more details on open access and the benefits of publishing with Molecular Psychiatry! | | | | | | | | | | | | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com | | | | | | | | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to The Pharmacogenomics Journal. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. | | | |
No comments:
Post a Comment
Keep a civil tongue.